Corrigendum to "Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants" Vaccine 15 (1997) 265-272 (DOI:10.1016/S0264-410X(96)00185-5);Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants

Vaccine

Volumn 15, Issue 3, 1997, Pages 265-272

  Rencher, Samantha D ^a   Lockey, Timothy D ^a   Srinivas, Ranga V ^a   Owens, Randall J ^a,b   Hurwitz, Julia L ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Frederick Medical Center   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

human immunodeficiency virus; vaccine induced immunity; vaccinia virus

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VIRUS RECOMBINANT;

EID: 0031044031     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.048     Document Type: Erratum

References (39)

1. Willey, R.L., Rutledge, R.A., Dias, S. et al. Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc. natn. Acad. Sci. U.S.A. 1986, 83, 5038-5042
2. Wong-Staal, F. Human immunodeficiency viruses and their replication. In: Virology (Eds Fields, B.N. and Knipe, D.M.). Raven Press, New York, 1990, p. 1529
3. Hirsch, M.S. and Curran, J. 1990. Human immunodeficiency viruses. Biology and medical aspects. In: Virology (Eds Fields, B.N. and Knipe, D.M.). Raven Press, New York, 1990, p. 1545
4. Paul, W.E. Fundamental Immunology. Raven Press, New York, 1993
5. Belshe, R.B., Bolognesi, D.P., Clements, M.L et al. HIV infection in vaccinated volunteers. J. Am. Med. Assoc. 1994, 272, 431-431
6. Fenner, F., Henderson, D.A., Arita, I., Jezek, Z. and Ladnyi, I.D. Smallpox and its Eradication. World Health Organization, Geneva, Switzerland, 1988, pp. 581-583
7. Moss, B. 1985. Relication of poxviruses. In: Virology (Fields, B.N.). Raven Press, New York, p. 685
8. Mackett, M., Smith, G.L and Moss, B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. natn. Acad'. Sci. U.S.A. 1982, 79, 7415-7419
9. Panicali, D. and Paoletti, E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. natn. Acad. Sci. U.S.A. 1982, 79, 4927-4931
10. Spriggs, M.K., Collins, PL, Tierney, E., London, W.T. and Murphy, B.R. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection. J. Virol. 1988, 62, 1293-1296
11. Scott, E.J., Ball, L.A., Young, K.K., Furze, J. and Wertz, G.W. Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J. Virol. 1986, 60, 607-613
12. Elango, N., Prince, G.A., Murphy, B.R., Venkatesan, S., Chanock, R.M. and Moss, B. Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proc. natn. Acad. Sci. U.S.A. 1986, 83, 1906-1910
13. Smith, G.L., Murphy, B.R. and Moss, B. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc. natn. Acad. Sci. U.S.A. 1983, 80, 7155-7159
14. Moss, B., Smith, G.L., Gerin, J.L. and Purcell, R.H. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 1984, 311, 67-69
15. Hu, S.-L., Zarling, J.M., Chinn, J. et al. Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus. Proc. natn. Acad. Sci. U.S.A. 1989, 86, 7213-7217
16. Cremer, K.J., Mackett, M., Wohlenberg, C., Notkins, A.L. and Moss, B. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 1985, 228, 737-740
17. Hu, S.-L., Fultz, P.N., McClure, H.M. et al. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature 1987, 328, 721-723
18. Cooney, E.L., Collier, A.C., Greenberg, P.D. et al. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 1991, 337, 567-572
19. Graham, B.S., Belshe, R.B., Clements, M.L. et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. J. Infect. Dis. 1992, 166, 244-252
20. Graham, B.S., Matthews, T.J., Belshe, R.B. et al. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. J. Infect. Dis. 1993, 167, 533-537
21. Cooney, E.L., McElrath, M.J., Corey, L. et al. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming wtih a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc. natn. Acad. Sci. U.S.A. 1993, 90, 1882-1886
22. McElrath, M.J., Corey, L., Berger, D. et al. Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting. J. Infect. Dis. 1994, 169, 41-47
23. Perales, M.A., Schwartz, D.H., Fabry, J.A. and Lieberman, J. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10, 27-35
24. Ratner, L., Haseltine, W., Patarca, R. et al. Complete nucleotide sequence of the AIDS virus HTLV-III. Nature 1985, 313, 277-284
25. Chakrabarti, S., Brechung, K. and Moss, B. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molec. Cell Biol. 1985, 5, 3403-3409
26. Hallenberger, S., Tucker, S.P., Owens, R.J., Bernstein, H.B. and Compans, R.W. Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein. Virology 1993, 193, 510-514
27. Ryan, K.W., Owens, R.J. and Hurwitz, J.L. Preparation and use of vaccinia virus vectors for HIV protein expression and immunization. In: Immunology Methods Manual (Ed. Lefkovits, I.). Academic Press, London, 1996
28. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989
29. Rhim, U.S., Cho, H.Y. and Huebner, R.J. Non-producer human cells induced by murine sarcoma virus. Int. J. Cancer 1975, 15, 23-29
30. Fuerst, T.R., Earl, P.L. and Moss, B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Molec. Cell Biol. 1987, 7, 2538-2544
31. Srinivas, R.V. and Hurwitz, J.L. HIV growth, measurement and neutralization. In: Immunology Methods Manual (Ed. Lefkovits, I.). Academic Press, London, 1996
32. Myers, G., Korber, B., Wain-Hobson, S., Smith, R.F. and Pavlakis, G.N. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1993
33. Cohen, J. AIDS vaccines: are researchers racing toward success, or crawling?. Science 1994, 265, 1373-1375
34. Benenson, A.S., Cherry, J.D., McIntosh, K. et al. Basic study and laboratory standardization. J. Infect. Dis. 1977, 135, 135-144
35. Connor, J.D., McIntosh, K., Cherry, J.D. et al. Primary subcutaneous vaccination. J. Infect. Dis. 1977, 135, 167-175
36. Cherry, J.D., Connor, J.D., McIntosh, K. et al. Standard percutaneous revaccination of children who received primary subcutaneous vaccination. J. Infect. Dis. 1977, 135, 176-182
37. Galasso, G.J., Mattheis, M.J., Cherry, J.D. et al. Summary. J. Infect. Dis. 1977, 135, 183-186
38. Wrin, T., Crawford, L, Sawyer, L, Weber, P., Sheppard, H.W. and Hanson, C.V. Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 1994, 7, 211-219
39. Burns, D.P.W. and Desrosiers, R.C. Envelope sequence variation, neutralizing antibodies and primate lentivirus persistence. Curr. Top. Microbiol. Immun. 1994, 188, 185-219